Corporate Vice President, General Manager - Infusion Systems · ICU Medical Inc (ICUI)

Dan Woolson

A named executive officer of ICU Medical in every fiscal year CompBrief holds from FY2019 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$1,839,920

Salary $363,462Stock awards $1,350,233Bonus $112,500

FY2019: $1,402,576

5th of 5 named executive officers at ICU Medical by FY2022 total.

5 named officers on file for ICU Medical, FY2022

Dan Woolson’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • ICUI’s disclosed peer group of 14 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ICU Medical’s whole pay program stands against its peers

  • ICU Medical’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ICUI→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 4, 2023 (DEF 14A).

Free

Get Dan Woolson’s full pay file as a PDF — free

More than this page: up to 10 years of Dan’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Dan Woolson compensation by year

ICU Medical Summary Compensation Table · all 2 fiscal years held
In US dollars, as ICU Medical reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2022
Salary$300,000$363,462
Bonus$90,000$112,500
Stock awards$1,000,201$1,350,233
Option awards$0$0
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$12,375$13,725
Total$1,402,576$1,839,920

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ICU Medical Inc DEF 14A filed April 4, 2023, accession 0000883984-23-000015, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ICU Medical Inc filed document, accession 0000883984-23-000015. Every figure is read from that document and cited to the page and table it appears in. Filed April 4, 2023.

$1.4M
$1.8M
FY19
FY22
SalaryBonusStock awardsAll other

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
PSU4,331$810,417—
RSU2,282$427,008—
PSU1,609$301,076—
RSU243$45,470—

Per the Outstanding Equity Awards at Fiscal Year-End table in ICU Medical Inc's FY2019 proxy; value at the fiscal year-end close, as the company printed it.

ICU Medical’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Vivek JainChairman of the Board and Chief Executive Officer$5,657,069
Christian VoigtlanderChief Operating Officer$3,651,623
Brian BonnellChief Financial Officer$3,619,123
Virginia SanzoneCorporate Vice President, General Counsel$2,052,827
Dan Woolson · this pageCorporate Vice President, General Manager - Infusion Systems$1,839,920

The full ICU Medical compensation record

free company brief

This page is one person within ICU Medical's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the ICU Medical proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ICU Medical's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Dan Woolson's compensation dossier · One-time report. No refunds.